“…Sanders et al ( 2001 ) revealed that NOS2 was down-regulated in rhinovirus infection, but this gene may be involved in development of SARS-CoV-2 infection. The enriched down-regulated genes found in this study include IL10 (Loebbermann et al 2012a , b ), IL13 (Castilow et al 2008 ), IL21 (Antunes et al 2019 ), CCR6 (Shi et al 2017 ), CXCL13 (Alturaiki et al 2018 ), CCL20 (Shi et al 2017 ), IL19 (Ermers et al 2011 ), IL20 (Ermers et al 2011 ), CD40 (Harcourt et al 2003a , b ), IL2 (Noma et al 1996 ), IL3 (Bertrand et al 2015 ), IL4 (Puthothu et al 2006 ), IL9 (Dodd et al 2009 ) and STAT6 (Srinivasa et al 2016) were responsible for progression of respiratory syncytial virus infection, but these genes may be linked with progression of SARS-CoV-2 infection. Many previous studies have confirmed the roles of enriched down-regulated genes such as IL12B (Mueller et al 2004 ), TNFRSF9 (Rodriguez et al 2019 ), TNFRSF14 (Soroosh et al 2014 ), IL17F (Wang et al 2016), CCR8 (Calado et al 2010 ), CCL18 (Malhotra et al 2019 ), CCL22 (Yang et al 2012 ), CXCL11 (Pineda-Tenor et al 2014 ), CX3CL1 (Bertin et al 2014 ), CXCL12 (Durrant et al 2014 ), CCR10 (Nakayama et al 2002 ), IFNA2 (Chen et al 2017), IFNB1 (Gagné et al 2017 ), IL7 (Golden‐Mason et al 2006), IL26 (Miot et al 2015 ), CXCR1 (Xu et al 2016 ), CEBPB (CCAAT enhancer binding protein beta) (Liu et al 2009 ), ETS1 (Posada et al 2000 ), STAT5A (Warby et al 2003 ), THY1 (Lu et al 2011 ), IL16 (Caufour et al 2001 ), HLA-B (Martin et al 2007 ), HLA-C (Apps et al 2013 ), HLA-DPA1 (Wasityastuti et al 2016 ), HLA-DPB1 (Lambert et al 2015 ), HLA-DQA1 (Tibbs et al 1996 ), HLA-DRB1 (Chi et al 2013 ), PSMB10 (Deng et al 2019 ), BCL2 (Zuckerman et al 2001), TOLLIP (toll interacting protein) (Li et al 2016a , b ), VCAM1 (Koraka et al 2004 ), RAG1 (Winkler et al 2017 ), IRF8 (Terry et al …”